Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bergenstal

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Postgraduate Medicine|February 1, 1985
Diabetic ketoacidosis. How to treat and, when possible, preventR M Bergenstal
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 23, 2001
Optimization of insulin therapy in patients with type 2 diabetesR M Bergenstal
The American Journal of Managed Care|August 25, 2001
Comprehensive management of patients with type 2 diabetes: establishing priorities of careD M Kendall, R M Bergenstal
The Journal of Clinical Investigation|May 1, 1985
Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transportE B Chang, R M Bergenstal, M Field
Journal of the American Dietetic Association|April 1, 1985
Dietary practices of persons with diabetes during insulin pump therapyA F Capper, S W Headen, R M Bergenstal
The Journal of Clinical Endocrinology and Metabolism|August 1, 1982
Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic womenS P Glickman, R L Rosenfield, R M Bergenstal, et al.
Diabetes, Obesity & Metabolism|October 20, 2012
Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeksR M Bergenstal, Y Li, T K Booker Porter, et al.
Diabetes|May 1, 1983
Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pumpR M Bergenstal, K S Polonsky, G Pons, et al.
Diabetes|August 1, 1985
Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapyR M Bergenstal, J Dupre, P M Lawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1979
Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like materialK H Gabbay, R M Bergenstal, J Wolff, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Postgraduate Medicine|February 1, 1985
Diabetic ketoacidosis. How to treat and, when possible, preventR M Bergenstal
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 23, 2001
Optimization of insulin therapy in patients with type 2 diabetesR M Bergenstal
The American Journal of Managed Care|August 25, 2001
Comprehensive management of patients with type 2 diabetes: establishing priorities of careD M Kendall, R M Bergenstal
The Journal of Clinical Investigation|May 1, 1985
Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transportE B Chang, R M Bergenstal, M Field
Journal of the American Dietetic Association|April 1, 1985
Dietary practices of persons with diabetes during insulin pump therapyA F Capper, S W Headen, R M Bergenstal
The Journal of Clinical Endocrinology and Metabolism|August 1, 1982
Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic womenS P Glickman, R L Rosenfield, R M Bergenstal, et al.
Diabetes, Obesity & Metabolism|October 20, 2012
Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeksR M Bergenstal, Y Li, T K Booker Porter, et al.
Diabetes|May 1, 1983
Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pumpR M Bergenstal, K S Polonsky, G Pons, et al.
Diabetes|August 1, 1985
Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapyR M Bergenstal, J Dupre, P M Lawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1979
Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like materialK H Gabbay, R M Bergenstal, J Wolff, et al.
Pageof 3